Keywords: |
adult; middle aged; vascular endothelial growth factor a; constipation; case report; bevacizumab; drug withdrawal; bone metastasis; pancreatic neoplasms; computer assisted tomography; nausea; vomiting; abdominal pain; fever; neuroendocrine tumor; gastrointestinal toxicity; liver metastasis; antibodies, monoclonal; pancreas tumor; octreotide; intestine perforation; oxaliplatin; angiogenesis inhibitors; peritoneum metastasis; carcinoma, neuroendocrine; 5 chloro 2,4 dihydroxypyridine plus oxonate potassium plus tegafur; pneumatosis intestinalis; pneumoperitoneum; pneumatosis cystoides intestinalis
|